Health Condition 1: null- Type 2 Diabetes mellitus with Hypertension Health Condition 2: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Intervention1: NIL: NIL
Sponsors
Synergia Life Sciences Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1.Male and female aged 28 to 65 who are confirmed with known diagnosis of type 2 diabetes mellitus with hypertension. 2.Willing to give informed consent.
Exclusion criteria
Exclusion criteria: 1.Patients who are suffering from any other systemic illness other than type 2 diabetes mellitus. 2.Patients who are on corticosteroids and oral contraceptives 3.Patients with seropositive status. 4.Pregnancy 5.Patients Participation in clinical trials evaluating investigational pharmaceuticals or biologics within 3 months or devices within 30 days of admission to the study. 6.Patients who are on coumarin analogues 7.Patients who are on Quinine Hydrochloride 8.History of alcohol. substance abuse or alcoholism, within the previous one year
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary objective of the study is to study the levels of Vitamin K2-7 in patients with type 2 diabetes mellitusTimepoint: 1 day | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: N/A | — |
Countries
India
Contacts
Public ContactDr Shashank Jadhav
Synergia Life Sciences Pvt. Ltd.
Outcome results
None listed